Because STS has a postulated significant role in the carcinogenicity of estrogens, STS is considered as a target enzyme for blocking estrogen-mediated carcinogenesis, and potent STS inhibitors have been developed and tested in rodents and in postmenopausal women with breast cancer [7]. This evidence concerns the gene STS and breast cancer.